Cancer remains one of the leading causes of death worldwide, and despite advancements in diagnosis and treatment, it continues to impose a significant health burden globally. Researchers have now started exploring various innovative methods, such as engineered nanomaterials (ENMs) that can enable targeted drug delivery to cancer cells. While promising, the in vivo behavior of pH-responsive ENMs, which continuously interact with body fluids once administered, remains poorly understood.